The parathyroid hormone (PTH) is a key regulator of serum calcium levels. It increases calcium levels by acting on bones, kidneys, and indirectly on the intestines via vitamin D activation. When calcium levels are low, PTH is secreted to restore balance.
✅ Softening of bones – Correct.
As PTH stimulates osteoclast activity, it increases bone resorption, releasing calcium into the bloodstream. Over time, excessive PTH or chronic stimulation of bone resorption can lead to decreased bone mineral density, resulting in bone softening (osteomalacia in adults, rickets in children). This is a compensatory mechanism to preserve serum calcium levels but at the expense of bone strength.
Let’s clarify why the other options are incorrect:
❌ Decline in parathyroid hormone levels – PTH levels increase, not decline, when calcium is low. A decline would worsen hypocalcemia.
❌ Inhibition of vitamin D synthesis – PTH actually stimulates the conversion of vitamin D to its active form (calcitriol) in the kidney, which then enhances intestinal calcium absorption.
❌ Excretion of calcium from kidneys – PTH promotes reabsorption of calcium in the distal tubules, reducing urinary calcium loss. It actually promotes phosphate excretion, not calcium.
❌ Hypertrophy of chondrocytes – This is more relevant to growth plate activity during development, not directly tied to serum calcium regulation or PTH action.